- Report
- December 2024
- 35 Pages
Italy
From €4631EUR$4,995USD£3,874GBP
- Report
- December 2024
- 30 Pages
France
From €4631EUR$4,995USD£3,874GBP
- Report
- December 2024
- 34 Pages
United Kingdom
From €4631EUR$4,995USD£3,874GBP
- Report
- December 2024
- 47 Pages
United States
From €4631EUR$4,995USD£3,874GBP
- Report
- November 2026
Global
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Global
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
China
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
United States
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
North America
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Europe
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Middle East
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Asia Pacific
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
China
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
United States
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
United Kingdom
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
North America
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Europe
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Middle East
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Asia Pacific
From €3699EUR$3,990USD£3,094GBP
- Report
- November 2026
Europe
From €3699EUR$3,990USD£3,094GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more